Current Cancer Drug Targets
Volume 19, 11 Issues, 2019
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Ranking and Category
-
135th of 229 in
Oncology
Most Accessed Articles
Polyploid Giant Cancer Cells (PGCCs): The Evil Roots of Cancer
, 2019; 19(5): 360-367.Junsong Chen, Na Niu, Jing Zhang, Lisha Qi, Weiwei Shen, Krishna Vanaja Donkena, Zhenqing Feng and Jinsong Liu*
DOI: 10.2174/1568009618666180703154233
The RNA Binding Protein HuR: a Promising Drug Target for Anticancer Therapy
, 2019; 19(5): 382-399.Mingxia Wu, Christy W.S. Tong, Wei Yan, Kenneth K.W. To* and William C.S. Cho*
DOI: 10.2174/1568009618666181031145953
Toxicology of Trastuzumab: An Insight into Mechanisms of Cardiotoxicity
, 2019; 19(5): 400-407.Jie An* and M. Saeed Sheikh*
DOI: 10.2174/1568009618666171129222159
EH-42: A Novel Small Molecule Induces Apoptosis and Inhibits Migration and Invasion of Human Hepatoma Cells through Suppressing STAT3 Signaling Pathway
, 2019; 19(7): 583-593.Qi-Zhe Gong, Di Xiao, Gui-Yi Gong, Jian Xu, Xiao-Dong Wen*, Feng Feng* and Wei Qu*
DOI: 10.2174/1568009619666181226094814
Exploring Proteomic Drug Targets, Therapeutic Strategies and Protein - Protein Interactions in Cancer: Mechanistic View
, 2019; 19(6): 430-448.Khalid Bashir Dar, Aashiq Hussain Bhat, Shajrul Amin, Syed Anjum, Bilal Ahmad Reshi, Mohammad Afzal Zargar, Akbar Masood and Showkat Ahmad Ganie*
DOI: 10.2174/1568009618666180803104631
HSF1 as a Cancer Biomarker and Therapeutic Target
, 2019; 19(7): 515-524.Richard L. Carpenter* and Yesim Gökmen-Polar
DOI: 10.2174/1568009618666181018162117
Combination Therapies Using Metformin and/or Valproic Acid in Prostate Cancer: Possible Mechanistic Interactions
, 2019; 19(5): 368-381.Linh N.K. Tran*, Ganessan Kichenadasse and Pamela J. Sykes
DOI: 10.2174/1568009618666180724111604
Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer
, 2019; 19(8): 595-630.Tatsuya Nagano*, Motoko Tachihara and Yoshihiro Nishimura
DOI: 10.2174/1568009619666181210114559
c-Myc Inhibitor 10074-G5 Induces Murine and Human Hematopoietic Stem and Progenitor Cell Expansion and HDR Modulator Rad51 Expression
, 2019; 19(6): 479-494.Merve Aksoz, Esra Albayrak, Galip Servet Aslan, Raife Dilek Turan, Lamia Yazgi Alyazici, Pınar Siyah, Emre Can Tuysuz, Serli Canikyan, Dogacan Yucel, Neslihan Meric, Zafer Gulbas, Fikrettin Sahin and Fatih Kocabas*
DOI: 10.2174/1568009618666180905100608
CT-707 Overcomes Resistance of Crizotinib through Activating PDPK1- AKT1 Pathway by Targeting FAK
, 2019; 19(8): 655-665.Caixia Liang, Ningning Zhang, Qiaoyun Tan, Shuxia Liu, Rongrong Luo, Yanrong Wang, Yuankai Shi* and Xiaohong Han*
DOI: 10.2174/1568009618666181031152140
  |
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA
View Full Editorial Board
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Webmaster Contact: info@benthamscience.net